Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Battling Negative Image Of Generics In Japan (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

[Editor's note: This is part two of a two-part feature on obstacles in promoting generics in Japan. Part one, which explored negative connotations associated with with the term "generic," appeared in PharmAsia News, March 19, 2009.]

You may also be interested in...



Japan's Pharma Companies Should Consolidate, Says Bayer Yakuhin Chairman

TOKYO - Japan's 1,270 pharmaceutical companies should consolidate to look more like the pharma industry in the U.S. or Germany, Bayer Yakuhin Chairman Norikazu Eiki said at the IBC Drug and Biologics conference in Tokyo Feb. 22

Japan's Pharma Companies Should Consolidate, Says Bayer Yakuhin Chairman

TOKYO - Japan's 1,270 pharmaceutical companies should consolidate to look more like the pharma industry in the U.S. or Germany, Bayer Yakuhin Chairman Norikazu Eiki said at the IBC Drug and Biologics conference in Tokyo Feb. 22

Japan Generic Drugs Show Only Minor Quality Problems, Ministry Study Shows

TOKYO - Japan's Ministry of Health, Labor and Welfare found that only two of 876 generic pharmaceutical products investigated showed minor quality problems while conducting a study linked to a national goal of promoting wider generics use

Related Content

UsernamePublicRestriction

Register

LL1132972

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel